7 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
chloroquine/HCQ), here is ... #Coronavirus #SARS-CoV ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-C Pharmacotherapy ... Irritable #Bowel #Syndrome ... #pharmacology # ... table #comparison ... #management #treatment
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... most effective treatments ... #CoronaVirus #Treatment ... #Management #Pandemic ... Pharmacotherapy #Pharmacology
IBS-D Pharmacotherapy

Loperamide
Rifaximin
Eluxadoline
Alosetron
Antispasmodics
Tricyclic antidepressants
SSRIs

#IBSD #IBS #Diarrhea #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-D Pharmacotherapy ... Irritable #Bowel #Syndrome ... #pharmacology # ... table #comparison ... #management #treatment
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
investigational treatments ... for COVID-19… ... InfectiousDiseases #COVID19 ... #Coronavirus #Treatment ... #Management #Pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... 19 - Zika virus ... Treatment: • Plasmapheresis ... #diagnosis #management ... #treatment #neurology
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... and cauda equina TREATMENT ... Guillain #Barre #Syndrome ... #diagnosis #management ... #neurology